Market Strategy
Page 1 • 2 itemsUnlock global pharma market strategy insights. Drive investment, M&A, and BD with data-driven intelligence for pharma leaders.
Jyong Biotech Advances Market Access Strategy for Botanical Drug Botreso® and PCP Pipeline
Jyong Biotech (NASDAQ: MENS) updates market access strategies for botanical drugs Botreso® and PCP, establishing competitive advantages in plant-derived therapeutics.
PMC Organometallix Announces 10-25% Price Increases Across All Product Lines Effective May 2026
PMC Organometallix will implement 10-25% price increases on all products globally starting May 1, 2026, citing significant market condition changes.